Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of diabetes
3.2.1.2 Technological advancement
3.2.1.3 Development of novel testing methodologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of devices
3.2.2.2 Stringent regulatory policies
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Strategic outlook matrix
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Laboratory-based testing
5.3 Point-of-care (POC) testing
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Immunoassays
6.3 Chromatography
6.4 Enzymatic assays
6.5 Boronate affinity chromatography
6.6 High-performance liquid chromatography
6.7 Other technologies
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals & clinics
7.3 Diagnostic laboratories
7.4 Homecare settings
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 ARKRAY, Inc.
9.3 Bio-Rad Laboratories, Inc.
9.4 Ceragem Medisys Inc.
9.5 Danaher Corporation
9.6 EKF Diagnostics
9.7 F. Hoffmann-La Roche Ltd.
9.8 HUMAN
9.9 Menarini Diagnostics s.r.l
9.10 PTS Diagnostics
9.11 Randox Laboratories Ltd.
9.12 SAKAE CO. LTD.
9.13 SEKISUI MEDICAL CO., LTD.
9.14 Siemens Healthineers AG
9.15 Trinity Biotech plc
